EGFR and non-small cell lung carcinoma: By contrast, Ishii et al. retrospectively showed that high CD73 expression correlated with favorable clinical efficacy of immunotherapy in patients with EGFR-mutated NSCLC who have developed resistance to EGFR-TKIs, although this study had some limitations such as the limited number of patients analyzed (63).